Cancer patient advocates represent those affected by cancer and have a broad view of
cancer research. They are involved in many diverse cancer research committees, where …

BACKGROUND Patient participation in well‐designed and conducted clinical trials enables
researchers to test new therapies. An understanding of the variables that possibly influence …

BACKGROUND: From the time of diagnosis to end of life, patients with primary brain tumors
experience challenges to maintain quality of life. While traditional research focuses on …

While awaiting PPI guidelines in neuro-oncology, the steps and strategies for meaningful
PPI in neurooncological research processes could be (1) develop a clear PPI plan with …

The American Academy of Neurology's (AAN) Neurology Now Books series answer the
questions and concerns of patients and caregivers with specific neurologic diseases who …

Goals of work The diagnosis and treatment of a brain tumour may result in long-term
changes in a patient's functional and social abilities and/or in a greatly reduced life span. A …

Specialized palliative care (PC) services have emerged to address symptoms and provide
end-of-life management for patients with brain tumors. The utilization patterns of PC in neuro …

e13585 Background: Brain metastases are the most common tumors to affect the central
nervous system. Treatment options have recently evolved with the use of targeted therapies …

This commentary discusses improving research advocacy as part of National Cancer
Institute (NCI) clinical trial activities in scientific steering committees and task forces between …

For the second time, The Brain Tumor Center of the Weill Cornell Brain and Spine Center, in
collaboration with Voices Against Brain Cancer, hosted The Brain Tumor Biotech Summit in …